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Winter and Cardiovascular Mortality
I read with interest the report by Sheth et al. (1) on seasonal variations
of coronary heart disease and stroke mortality, and I would like to
present a new analysis of data culled from an old Brazilian study
performed in Sa˜o Paulo, a city situated at the Tropic of Capricorn.
Between January 1932 and December 1941, Chiaverini and Rey
(2) studied all deaths from congestive heart failure (CHF) con-
firmed by the city’s unique autopsy service. They concluded that
most of the CHF deaths occurred during the winter, which in Sa˜o
Paulo runs from June to August. I examined the mortality data
during a shorter period (July 1939 to December 1941), because
there was better weather data, and confirmed Chiaverini and Rey’s
results. In my analysis, CHF deaths were 28.8% higher during the
winter months as compared with the summer months (December
to February). Minimal monthly temperature (annual range 7.7 to
18.1°C) had a persistent association with CHF deaths (r 5 20.31,
p 5 0.0456) after multiple linear regression analysis for humidity,
hours of sunlight, temperature range and CHF mortality. These
results from historic data are in concordance with a recent report
analyzing coronary artery disease mortality in Hawaii (3), which is
located at an equivalent latitude as Sa˜o Paulo, but in the Northern
Hemisphere. However, the most relevant finding from Chiaverini and
Rey’s study is that most of the CHF cases were categorized as
“nonatherosclerotic diseases.” During the 1940s in Sa˜o Paulo (4), the
etiology of CHF was rheumatic (23.6%), hypertensive heart disease
(23.1%), atherosclerosis (20.6%), Chagas’ disease (10.8%) and syphilis
(7.1%). Given these data, it is plausible to speculate that seasonal
variations in cardiovascular mortality may be due to factors directly
associated with impairment of myocardial contractility, such as ar-
rhythmias and increasing blood pressure, rather than to factors more
specifically related to rupture of coronary atherosclerotic plaque.
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Dynamic Left Ventricular Outflow
Tract Obstruction as a Potential
Mechanism of Myocardial Rupture
After Acute Myocardial Infarction
We read with great interest the study of Becker et al. (1), who
investigated the incidence and predictive factors of fatal cardiac
rupture in patients treated with thrombolysis enrolled in the
Thrombolysis and Thrombin Inhibition in Myocardial Infarction
(TIMI-9) study. The authors reported female gender and age as
independent risk factors for fatal cardiac rupture. Of note, they did
not observe a significant relation between anticoagulation therapy
and cardiac rupture. In contrast, the incidence of rupture was
higher in patients with anterior myocardial infarction not receiving
early angiotensin-converting enzyme inhibition and beta-blockers.
Although the study did not address directly pathophysiologic
mechanisms of the rupture, the authors speculated that changes in
collagen matrix associated with aging and, potentially, with female
gender may underlie the higher risk for mortality. This sounds
plausible, but nevertheless, the authors do not report some clini-
cally relevant information such as the extent of coronary artery
disease and overall or regional left ventricular (LV) function.
Likewise, they do not address triggers that may precipitate the
occurrence of the rupture. However, Oliva et al. (2) reported that
myocardial rupture is often preceded by particular signs—namely
emesis, restlessness, pericarditis, alterations of the T waves and
abrupt episodes of bradycardia or hypotension. The latter signs
deserve closer attention by clinicians. Hypotension or bradycardia
is often present owing to the activation of LV mechanoreceptors in
patients with LV outflow tract (LVOT) obstruction. We have
recently reported a novel observation of a dynamic LVOT obstruc-
tion with systolic anterior motion of the mitral leaflets in patients
after acute anterior myocardial infarction that preceded a cardiac
rupture or intraventricular septal defect (3). The LVOT obstruc-
tion was observed in women with nonhypertrophied ventricles and
calcified posterior mitral annulus and/or thickened mitral leaflets
who presented with hyperdynamic contraction of the noninfarct-
related artery segments. Since this publication (3), we observed a
third myocardial rupture also preceded by LVOT obstruction in a
57-year-old man. Based on our observations, we postulated that
the presence of the LVOT obstruction led to an increase in the
end-systolic wall stress of the infarct segments, which may repre-
sent a direct mechanical insult to a weakened necrotic tissue. This
observation has several potential clinical implications. First, it
implies that in patients with a large anterior infarction and
hyperkinetic noninfarct segments, particular attention should be
paid to LVOT flow dynamics, especially in women with abnor-
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malities of the mitral valve apparatus. Second, in such patients
aggressive treatment with vasodilators should be avoided because
they may precipitate or worsen the dynamic obstruction. In
contrast, beta-blockers should blunt the hyperdynamic contraction
and thus, in addition to the reduction of arrhythmias and work
load, prevent the fatal cardiac rupture (4). We believe that
discussion of these mechanisms could stimulate other investigators
to look carefully at LVOT dynamics in patients with anterior
myocardial infarction to determine whether compensatory hyper-
dynamic contractions of the basis of the heart may indeed be
deleterious in these patients.
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REPLY
The work of Bartunek et al. (1) is well known and respected in the
field of echocardiography, and their elegant work concerning the
mechanism of outflow tract obstruction after aortic valve replace-
ment for aortic stenosis represents the definitive study on this
subject. We are greatly interested in their more recent work
concerning cardiac rupture in two elderly women with anterior
myocardial infarction, dynamic outflow tract gradient and a doc-
umented ventricular septal defect in one patient and possible left
ventricular free wall rupture in the other.
Their hypothesis of increased wall stress, occasioned by dynamic
outflow obstruction due to hyperdynamic basal wall contraction as
a possible trigger to cardiac rupture, is novel and plausible. We
have recently observed an instance where outflow tract obstruction,
as demonstrated by transesophageal echocardiography, was the
cause for profound hypotension in a patient who had a large
anteroapical myocardial infarction.
The pressure theory of cardiac rupture is widely quoted (2) and,
in combination with a vulnerable myocardium, provides the re-
quired substrate for an often fatal event. Although our study did
not have premorbid echocardiographic information (3), data de-
rived from the Late Assessment of Thrombolytic Efficacy (LATE)
study (4), National Registry of Myocardial Infarction (5) and
Thrombolysis and Thrombin Inhibition in Myocardial Infarction
(TIMI-9) experience (3) support Bartunek et al.’s hypothesis in the
following ways. First, an anterior site of infarction was present in
.50% of patients. Second, although a previous myocardial infarc-
tion was an independent risk factor for cardiac death, it was not
common in patients with a fatal cardiac rupture. This observation
suggests that preservation of left ventricular performance in the
noninfarct zone is a prerequisite for rupture and is supported by the
relatively low proportion of patients with cardiac rupture initially
classified as Killip class III or higher (4). Lastly, the protective
effect of beta-blockers is consistent with an intracavity pressure
trigger for cardiac rupture. Despite the fact that angiotensin-
converting enzyme (ACE) inhibitors and other vasodilators could
potentially worsen a dynamic obstruction, similar to large-scale
trials (6), we observed an inverse relation between ACE inhibitor
use and the occurrence of cardiac rupture (odds ratio 0.27, p ,
0.0001). Clearly, several mechanisms contribute to cardiac rupture.
We agree with Bartunek et al. that future investigations carried
out among patients with myocardial infarction must include
studies of dynamic change in ventricular cavity performance as a
means to better understand the conditions required for cardiac
rupture and, more importantly, its prevention.
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